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ABSTRACT. Short-axis cine images are acquired during cardiac MRI in order to
determine variables of cardiac left ventricular (LV) function such as ejection fraction
(EF), end-diastolic volume (EDV), end-systolic volume (ESV), stroke volume (SV) and LV
mass. In cardiac perfusion assessments this imaging can be performed in the temporal
window between first pass perfusion and the acquisition of delayed enhancement
images in order to minimise overall scanning time. The objective of this study was to
compare pre- and post-contrast short-axis LV variables of 15 healthy volunteers using a
two-dimensional cardiac-gated segmented cine true fast imaging with steady state
precession sequence and a 3.0 T MRI unit in order to determine the possible effects of
contrast agent on the calculated cardiac function variables. Image analysis was carried
out using semi-automated software. The calculated mean LV mass was lower when
derived from the post-contrast images, relative to those derived pre-contrast (102 vs
108.1g, p,0.0001). Small but systematic significant differences were also found
between the mean pre- and post-contrast values of EF (69.4% vs 68.7%, p,0.05), EDV
(142.4 vs 143.7ml, p,0.05) and ESV (44.2 vs 45.5ml, p,0.005), but no significant
differences in SV were identified. This study has highlighted that contrast agent
delivery can influence the numerical outcome of cardiac variables calculated from MRI
and this was particularly noticeable for LV mass. This may have important implications
for the correct interpretation of patient data in clinical studies where post-contrast
images are used to calculate LV variables, since LV normal ranges have been
traditionally derived from pre-contrast data sets.
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Cardiac MRI (CMRI) is a reproducible [1], non-
invasive tool which provides a rapid and accurate [2, 3]
cardiac assessment in any desired imaging plane without
the use of ionising radiation. CMRI is considered by
many to be the reference standard for the assessment of
left ventricular (LV) variables [4] such as volumes, mass
and function, with steady-state free precession (SSFP)
currently being considered as the sequence of choice for
carrying out such assessments [5].
It is possible to obtain cardiac images of good
diagnostic quality in high-field MRI without the need
for gadolinium (Gd)-based contrast agents; however,
contrast agents are required during cardiac perfusion to
aid the evaluation of different patterns of myocardial
scarring seen in myocardial infarctions and cardiom-
yopathies [6]. In such cardiac studies, the short-axis
images used to derive ventricular volumes and mass
measurements are usually acquired before the adminis-
tration of contrast agent. In studies where perfusion
analysis is required, there is a temporal window of
approximately 10–15min available between ‘‘first pass’’
and ‘‘delayed enhancement’’ acquisitions. This provides
the opportunity to obtain short-axis LV data sets during
this period, thus minimising the length of time that the
patient is in the scanner.
Results of previous studies have identified that the
contrast conditions at the left ventricle can influence the
magnitude of the resulting LV parameters. For example,
a previous comparison of spoiled-gradient echo and
steady-state gradient echo sequences for the assessment
of LV function identified significant differences in the
resulting LV variables [7]. Other studies have also
investigated the use of inversion recovery gradient-echo
(IR-GRE) techniques for combined post-contrast perfu-
sion and LV mass analysis in patients [8, 9] and these
have been compared with pre-contrast SSFP methods. In
the latter of these reports, significant LV mass differences
were identified between IR-GRE and SSFP for pre- and
post-contrast LV mass assessment, with SSFP being
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validated as the more accurate measure of LV mass using
ex vivo methods.
To date, previous assessments of pre- and post-
contrast LV variables have been undertaken using
different pulse sequences. With this information in
mind, our aim was to establish if differences between
LV variables might exist on the basis of whether the data
were collected before or after the delivery of a Gd
contrast agent, using a single pulse sequence only (SSFP).
This study specifically addresses LV analysis at 3 T in
order to determine what effect the administration of
contrast agent has on the calculated measurement of
ejection fraction (EF), end-diastolic volume (EDV), end-
systolic volume (ESV), stroke volume (SV) and LV mass.
A correct understanding of any such differences is
deemed important, since MRI-derived normal human
left and right ventricular ranges are routinely defined
from pre-contrast short-axis images [10]. Identifying and
acknowledging such differences may also allow the most
appropriate post-scan clinical management of patients
with LV dysfunction.
Methods and materials
15 healthy volunteers [8 females (average age 48 years,
range 41–61 years) and 7 males (average age 59 years,
range 48–71 years)] with no history of atherosclerotic
disease, primary muscle disease, statin therapy or
serious illness were selected for imaging from a large
database of individuals who were participating in a
separate local MRI cardiovascular screening study.
Exclusion criteria included age of less than 40 years,
known alcohol abuse, pregnancy, claustrophobia and
any other known contraindication to MRI. Approval for
this study was obtained from the local ethics committee
and volunteers provided written informed consent.
The sample size calculation for our investigation was
based on information obtained from previous CMRI
studies. For example, Grothues et al [11] studied various
clinical subject groups using CMRI and the typical
minimum sample size required to detect a clinically
significant 10 g change in LV mass with a power of 90%
and an a error of 0.05 was 13. Our initial hypothesis was
that the influence of the contrast agent on the myocardial
blood pool signal in our work might result in similar LV
parameter differences. Based on this, a decision was
taken to optimise our statistical power by increasing
recruitment slightly to include 15 healthy volunteers.
This study was completed over a 5-month period with
the pre- and post-contrast stacks of short-axis images
(slice thickness 6mm, interslice gap 4mm) for each
volunteer being obtained during a single imaging session
using a 3T Magnetom Trio MRI scanner (Siemens,
Erlangen, Germany). Initially, pre-contrast images were
acquired (during end-expiration breath-hold) from the
atrioventricular ring to the apex of the heart using a two-
dimensional cardiac-gated segmented cine true fast
imaging with steady state precession sequence with spine
matrix and six-element body-array matrix radio fre-
quency coils. One or two slices were imaged per breath-
hold, depending on the ECG R–R wave interval of the
volunteer. Imaging parameters included an in plane data
acquisition matrix of 1736256, a field of view ranging
from 320 to 420 mm (depending on patient size), repeti-
tion time 3.4 ms, echo time 1.5 ms and flip angle 50u. Post-
contrast images (using the same imaging parameters)
were subsequently obtained after iv injection of 10 ml of
Gd-based contrast agent (Dotarem, Villepinte, France) via
a power injector (Spectris Solaris EP, MedRad Inc.,
Warrendale, PA) followed by a saline flush of 20 ml.
Contrast was administered at a consistent rate (1.5ml s21)
for all volunteers. The elapsed time between the admin-
istration of contrast agent and the acquisition of the mid-
slice at end-diastole in the post-contrast short-axis stack
consistently fell between 4 and 5min for each volunteer.
Image analysis was performed on a remote Siemens
multi-modality workstation using ARGUS software
[v. VB15 (Siemens, Erlangen, Germany)]. AnMRI physicist
with 4 years9 experience of quantitative CMRI analysis
(a) (b)
Figure 1. A comparison of pre- and post-contrast short-axis images (at end diastole) of one volunteer showing (a) pre-contrast
administration and (b) post-contrast administration.
S Matthew, S J Gandy, R S Nicholas et al
e344 The British Journal of Radiology, July 2012
(Segmenter 1) performed semi-automated placement of
endocardial and epicardial myocardial borders, from base
to apex, on all slices pertaining to end-diastole (Figure 1)
and end-systole. Each contour was defined by manually
placing a circular region of interest over each myocardial
border and then invoking an automated edge-detection
algorithm to optimise the placement of these contours.
Finally, manual adjustment of each epicardial and endo-
cardial contour was undertaken where required to ensure
optimised precision and consistency of contour placement.
Papillary muscles and trabeculae were included in the LV
mass when they were indistinguishable from the endocar-
dial border, but otherwise they were assigned to the blood
pool volume. Care was taken to ensure that slice selection
at end-diastole and end-systole was consistent between the
pre- and post-contrast images of each volunteer selected for
this study, and images were retrospectively reviewed to
ensure that the inclusion or exclusion of papillary muscles
was consistent between the pre- and post-contrast images
of each volunteer.
Segmenter 1 repeated the analysis of 10 randomly
selected short-axis data sets (4 pre-contrast and 6 post-
contrast) to establish intraobserver reproducibility. A
second MR physicist segmenter with 6 years of cardiac
MRI analysis experience (Segmenter 2) repeated the
analysis on seven pre-contrast data sets from the study
in order to establish interobserver reproducibility.
Segmenter knowledge/memory effects were minimised
by ensuring that no individual segmentations were
repeated within a 1 month period.
Statistical testing for normality of data was undertaken
using the Shapiro–Wilks test (SPSS; IBM Corporation,
Somers, NY) and subsequently the pre- and post-contrast
values of each parameter were compared using a paired
t-test (assuming equal variances) (Sigma Plot, v. 10;
Systat Software, Inc., San Jose, CA). Results of the t-tests
were deemed significant if p,0.05. Bland–Altman
analysis was implemented in order to investigate and
highlight intra- and interobserver repeatability differ-
ences for each of the cardiac MRI measurements utilised.
Results
All images were acquired successfully, resulting in 15
pairs of pre- vs post-contrast data sets for comparison.
Initial inspection of the images showed subtle qualita-
tive differences to the contrast between the myocar-
dium, the blood pool and other surrounding tissues
(Figure 1).
A significant reduction to the mean EF and LV mass
parameters was noted following delivery of Gd contrast
agent (Table 1). Additionally, a small but significant
increase in the mean EDV and ESV parameters was also
noted after contrast agent delivery. Individual values (i.e.
on a per-volunteer basis) for LV mass were consistently
lower for every volunteer following contrast agent, with
values ranging from 21.6 to 211.3 g (mean 26.1 g,
median 25.0 g). The EF in 12 out of 15 volunteers was
also reduced, with values ranging from 22.4% to 1.3%,
(mean20.7%, median21.0%). In contrast, the majority of
calculated EDV (n510) and ESV (n512) parameters
displayed a small increase with the administration of
contrast agent, with values ranging from 24.3 to 4.1ml
(mean 1.3ml, median 2.1ml) and 22.5 to 3.7ml (mean
1.3ml, median 1.7ml), respectively. Stroke volume was
found to be particularly stable; no mean pre- vs post-
contrast change of any significance was noted.
No correlations were identified between the age, sex
and body mass index of the volunteers and the extent of
change between the calculated pre- and post-contrast
values obtained for each cardiac parameter.
Reproducibility
Intra- and interobserver assessments of single time
point, test re-test and repeated measures for each LV
parameter made by Segmenters 1 and 2 are highlighted
in Table 2.
Bland–Altman plots are displayed for the LVmass data,
illustrating the variation between pre- and post-contrast
LV mass variables (Figure 2), as well as the variation
Table 1. Results of analysis performed on pre- and post-
contrast data sets by Segmenter 1
Parameter Pre-contrast Post-contrast
EF (%) 69.4¡5.3 68.7¡5.0a
EDV (ml) 142.4¡34.5 143.7¡33.7a
ESV (ml) 44.2¡14.9 45.5¡14.6a
SV (ml) 98.3¡22.6 98.2¡21.9
LV mass (g) 108.1¡26.5 102.0¡26.6a
Mean values ¡ standard deviation for all pre- and post-
contrast cardiac parametres of ejection fraction (EF), end-
diastolic volume (EDV), end-systolic volume (ESV), stroke
volume (SV) and left ventricular mass (LV mass).
aDenotes significant difference at p,0.05.
Table 2. Intra- and interobserver reproducibility of pre- and post-contrast data sets
Intraobserver analysis (n510) Interobserver analysis (n57)
Parameter 1st analysis 2nd analysis Segmenter 1 Segmenter 2
EF (%) 70.0¡6.2 69.0¡5.4 71.9¡4.4 72.1¡4.8
EDV (ml) 141.6¡28.5 142.1¡28.0 126.7¡25.3 128.5¡27.6
ESV (ml) 44.3¡13.0 44.4¡12.2 35.7¡8.5 35.9¡9.7
SV (ml) 97.3¡19.8 97.8¡19.9 91.2¡19.4 92.6¡20.1
LV mass (g) 108.7¡19.7 108.4¡19.6 103.7¡23.0 105.0¡20.7
Segmenter 1 analysed 10 data sets twice whereas Segmenter 2 performed repeat analysis on seven data sets previously analysed
by Segmenter 1. Data are presented for ejection fraction (EF), end-diastolic volume (EDV), end-systolic volume (ESV), stoke
volume (SV) and left ventricular mass (LV mass) as mean¡standard deviation. No significant differences between the means of
any of the parameters were identified.
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between intraobserver repeated measures (Figure 3). It
can be seen that the spread of data in Figure 2 is greater
than that in Figure 3, with the mean ‘‘shift from zero’’ in
Figure 2 highlighting the consistent post-contrast reduc-
tion in the LV mass values.
Discussion
This study has demonstrated significant changes to
pre- vs post-contrast cardiac MRI values of EF, EDV, ESV
and LV mass in this cohort of healthy volunteers, with
the calculated values of EF and LV mass decreasing after
contrast delivery and EDV and ESV increasing after
contrast delivery. By far the largest of these changes was
found for LV mass.
These data appear to be consistent with the hypothesis
that the administration of contrast agent leads to a
change in the visual detection of the endocardial and
epicardial borders during image analysis. The presence
of contrast agent in the left ventricle improves the high-
contrast detection of the endocardial border and this
appears to result in an LV mass reduction together with
increased blood pool volumes during segmentation.
However, we do acknowledge that this has not been
independently measured.
Every effort was made to address possible covariate
effects such as minor image slice positioning differences
and segmenter reproducibility variations. Care was taken
to minimise systematic errors andmaintain consistency in
the acquisition and analysis of all data sets, resulting in
minimal intra- and interobserver variation. Experienced
radiographic technicians participated in order to ensure
standardised data acquisition methods and a single
experienced segmenter carried out the analysis of all data
sets since cardiac analysis (in particular LV mass) is
known to be more reproducible for intraobserver assess-
ments [12].
The relative differences between our pre-contrast and
post-contrast LV mass measurements are similar to those
reported by Stephensen et al [9]. This is reassuring from
the point of view of study consistency, although in this
study our data imply that LV mass differences have
arisen from the presence of the contrast agent as opposed
to the particular pulse sequence used.
The clinical significance of the parameter differences
noted in this work is most likely to be dependent upon
the wider context of the particular cardiac MRI investi-
gation under question. For example, if precise follow-up
data are being assessed as part of a quantitative
longitudinal study, then a 7 g drop in LV mass is highly
likely to be regarded as significant. However, if the data
are being used for a quick single time-point quantitative
assessment of a particular cardiac condition then these
differences may be less important. It is accepted that the
pre- and post-contrast differences between the para-
meters of EF, EDV and ESV are far smaller and as such
we have reported these from the perspective of an
interesting and consistent observation.
It is acknowledged that this study has some limita-
tions. It is possible that a larger sample size might have
resulted in the detection of more clear-cut changes to
each parameter since the systematic differences
reported in our work were rather small. It would also
be advantageous to see whether the changes found
could be replicated in defined patient groups. However
our sample size is consistent with other cardiac MRI
studies of a similar nature [11, 13] and this was
Figure 3. Variation of intraobserver
measurements obtained by segmen-
ter 1 for left ventricular (LV) mass. It
can be seen that the spread of data
is less than that of Figure 2 and that
the variation is spread around zero.
Figure 2. Variations between pre-
and post-contrast left ventricular
(LV) mass values obtained by seg-
menter 1. The mean ‘‘shift from
zero’’ highlights the consistent post-
contrast reduction in LV mass values.
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carefully considered during the design phase of this
work.
Finally, our ‘‘standard dose’’ approach for contrast
agent delivery is different from routine clinical practice
in CMRI perfusion where a weight-corrected dose would
normally be delivered. The reason for this design
compromise was that our cardiac imaging was per-
formed within the framework of a larger whole-body
MRA investigation where a standard dose approach was
required as part of this work. However, from a clinical
perspective the inclusion criteria for our subjects (see
methods and materials) was such that a formal clinical
assessment of cardiac perfusion involving weight-cor-
rected dose was not deemed essential for this cohort.
Conclusion
This pilot study has demonstrated that the adminis-
tration of contrast agent in this cohort of healthy
volunteers has significantly altered the calculated cardiac
parameters of EF, EDV, ESV and particularly LV mass.
Future studies involving cardiac patients are warranted
since systematic differences in LV mass may need to be
considered carefully in the context of clinical decision-
making. It is also recommended that image analysis is
undertaken on either pre- or post-contrast data sets and
that this choice is kept consistent for the case of repeat
scans or longitudinal studies.
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